|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.105 CAD | +5.00% |
|
+5.00% | -41.67% |
| Apr. 25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
| Mar. 22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
Valeo Pharma Inc. provided revenue guidance for the fourth quarter of 2022. The company expects revenues in the fourth quarter to exceed $11 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -41.67% | 7.62M | |
| +34.35% | 693B | |
| +29.39% | 584B | |
| -3.49% | 372B | |
| +20.15% | 332B | |
| +6.19% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +9.21% | 168B |
VALEO PHARMA INC. 